425 related articles for article (PubMed ID: 29298116)
1. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Vetiska S; Bonilla X; Boudreau E; Jauhiainen S; Rezai Jahromi B; Khyzha N; DiStefano PV; Suutarinen S; Kiehl TR; Mendes Pereira V; Herman AM; Krings T; Andrade-Barazarte H; Tung T; Valiante T; Zadeh G; Tymianski M; Rauramaa T; Ylä-Herttuala S; Wythe JD; Antonarakis SE; Frösen J; Fish JE; Radovanovic I
N Engl J Med; 2018 Jan; 378(3):250-261. PubMed ID: 29298116
[TBL] [Abstract][Full Text] [Related]
2. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
Fish JE; Flores Suarez CP; Boudreau E; Herman AM; Gutierrez MC; Gustafson D; DiStefano PV; Cui M; Chen Z; De Ruiz KB; Schexnayder TS; Ward CS; Radovanovic I; Wythe JD
Circ Res; 2020 Aug; 127(6):727-743. PubMed ID: 32552404
[TBL] [Abstract][Full Text] [Related]
3. Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype.
Gao S; Nelson J; Weinsheimer S; Winkler EA; Rutledge C; Abla AA; Gupta N; Shieh JT; Cooke DL; Hetts SW; Tihan T; Hess CP; Ko N; Walcott BP; McCulloch CE; Lawton MT; Su H; Pawlikowska L; Kim H
J Neurosurg; 2022 Jan; 136(1):148-155. PubMed ID: 34214981
[TBL] [Abstract][Full Text] [Related]
4. KRAS Activating Signaling Triggers Arteriovenous Malformations.
Cheng F; Nussinov R
Trends Biochem Sci; 2018 Jul; 43(7):481-483. PubMed ID: 29748115
[TBL] [Abstract][Full Text] [Related]
5. KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations.
Oka M; Kushamae M; Aoki T; Yamaguchi T; Kitazato K; Abekura Y; Kawamata T; Mizutani T; Miyamoto S; Takagi Y
World Neurosurg; 2019 Jun; 126():e1365-e1373. PubMed ID: 30902772
[TBL] [Abstract][Full Text] [Related]
6. Selective Endothelial Hyperactivation of Oncogenic KRAS Induces Brain Arteriovenous Malformations in Mice.
Park ES; Kim S; Huang S; Yoo JY; Körbelin J; Lee TJ; Kaur B; Dash PK; Chen PR; Kim E
Ann Neurol; 2021 May; 89(5):926-941. PubMed ID: 33675084
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations.
Hong T; Yan Y; Li J; Radovanovic I; Ma X; Shao YW; Yu J; Ma Y; Zhang P; Ling F; Huang S; Zhang H; Wang Y
Brain; 2019 Jan; 142(1):23-34. PubMed ID: 30544177
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in intracranial arteriovenous malformations.
Goss JA; Huang AY; Smith E; Konczyk DJ; Smits PJ; Sudduth CL; Stapleton C; Patel A; Alexandrescu S; Warman ML; Greene AK
PLoS One; 2019; 14(12):e0226852. PubMed ID: 31891627
[TBL] [Abstract][Full Text] [Related]
9. KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway.
Xu H; Huo R; Li H; Jiao Y; Weng J; Wang J; Yan Z; Zhang J; Zhao S; He Q; Sun Y; Wang S; Cao Y
Stroke Vasc Neurol; 2023 Jun; 8(3):197-206. PubMed ID: 36418055
[TBL] [Abstract][Full Text] [Related]
10. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-3131 derived from endothelial cells with KRAS mutation promotes EndMT by targeting PICK1 in brain arteriovenous malformations.
He Q; Huo R; Wang J; Xu H; Zhao S; Zhang J; Sun Y; Jiao Y; Weng J; Zhao J; Cao Y
CNS Neurosci Ther; 2023 May; 29(5):1312-1324. PubMed ID: 36718590
[TBL] [Abstract][Full Text] [Related]
12. Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation.
Priemer DS; Vortmeyer AO; Zhang S; Chang HY; Curless KL; Cheng L
Hum Pathol; 2019 Jul; 89():33-39. PubMed ID: 31026472
[TBL] [Abstract][Full Text] [Related]
13. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
[TBL] [Abstract][Full Text] [Related]
14. Review of treatment and therapeutic targets in brain arteriovenous malformation.
Pan P; Weinsheimer S; Cooke D; Winkler E; Abla A; Kim H; Su H
J Cereb Blood Flow Metab; 2021 Dec; 41(12):3141-3156. PubMed ID: 34162280
[TBL] [Abstract][Full Text] [Related]
15. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Fish JE; Radovanovic I
N Engl J Med; 2018 Apr; 378(16):1561-1562. PubMed ID: 29669234
[No Abstract] [Full Text] [Related]
16. Detection of MAPK/ERK pathway proteins and KRAS mutations in adenomatoid odontogenic tumors.
Bologna-Molina R; Ogawa I; Mosqueda-Taylor A; Takata T; Sánchez-Romero C; Villarroel-Dorrego M; Takeda Y; Mikami T
Oral Dis; 2019 Mar; 25(2):481-487. PubMed ID: 30294831
[TBL] [Abstract][Full Text] [Related]
17. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Morita H; Komuro I
N Engl J Med; 2018 Apr; 378(16):1561. PubMed ID: 29671469
[No Abstract] [Full Text] [Related]
18. Recent Advances in Basic Research for Brain Arteriovenous Malformation.
Barbosa Do Prado L; Han C; Oh SP; Su H
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731545
[TBL] [Abstract][Full Text] [Related]
19. Somatic Mosaicism in the Pathogenesis of de novo Cerebral Arteriovenous Malformations: A Paradigm Shift Implicating the RAS-MAPK Signaling Cascade.
Peterson K; Coffman S; Zehri A; Anzalone A; Xiang Z; Wolfe S
Cerebrovasc Dis; 2021; 50(2):231-238. PubMed ID: 33556951
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations.
Goss JA; Konczyk DJ; Smits PJ; Kozakewich HPW; Alomari AI; Al-Ibraheemi A; Taghinia AH; Dickie BH; Adams DM; Fishman SJ; Mulliken JB; Warman ML; Greene AK
Angiogenesis; 2019 Nov; 22(4):547-552. PubMed ID: 31486960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
